Psychophysiological reactions in humans during an open sea dive to 500 m with a hydrogen-helium-oxygen mixture - PubMed (original) (raw)
Psychophysiological reactions in humans during an open sea dive to 500 m with a hydrogen-helium-oxygen mixture
J H Abraini et al. J Appl Physiol (1985). 1994 Mar.
Abstract
Six commercial divers were investigated for neurological and psychosensorimotor responses during an open sea dive to 500 m with a hydrogen-helium-oxygen mixture containing 49% hydrogen. Results showed only moderate neurological symptoms of high-pressure nervous syndrome, whereas the narcotic effect of hydrogen was detectable, as investigated by psychosensorimotor tests. Nevertheless, the divers successfully carried out the main purpose of the operational dive, which was to prove the feasability of such diving methods by connecting specific elements of an offshore oil installation. Finally, these data support the hypothesis that hydrogen can alleviate some of the symptoms of the high-pressure nervous syndrome and can constitute a useful gas for commercial diving, as it decreases the density of the breathing mixture and therefore improves the living conditions, work, and comfort of the divers. Nevertheless, the present results underscore the relevance of research on individual susceptibility to pressure environment regardless of the composition of the breathing mixture.
Similar articles
- Effects of a H2-He-O2 mixture on the HPNS up to 450 msw.
Rostain JC, Gardette-Chauffour MC, Lemaire C, Naquet R. Rostain JC, et al. Undersea Biomed Res. 1988 Jul;15(4):257-70. Undersea Biomed Res. 1988. PMID: 3212843 - Evidence for inert gas narcosis mechanisms in the occurrence of psychotic-like episodes at pressure environment.
Abraini JH. Abraini JH. Neuroreport. 1995 Nov 27;6(17):2435-9. doi: 10.1097/00001756-199511270-00036. Neuroreport. 1995. PMID: 8747169 - Brainstem auditory evoked potentials during a helium-oxygen saturation dive to 450 meters of seawater.
Lorenz J, Brooke ST, Petersen R, Török Z, Wenzel J. Lorenz J, et al. Undersea Hyperb Med. 1995 Sep;22(3):229-40. Undersea Hyperb Med. 1995. PMID: 7580764 - Recreational technical diving part 2: decompression from deep technical dives.
Doolette DJ, Mitchell SJ. Doolette DJ, et al. Diving Hyperb Med. 2013 Jun;43(2):96-104. Diving Hyperb Med. 2013. PMID: 23813463 Review. - Priestley lecture 1986. On the science of deep-sea diving--observations on the respiration of different kinds of air.
Smith EB. Smith EB. Undersea Biomed Res. 1987 Jul;14(4):347-69. Undersea Biomed Res. 1987. PMID: 3307084 Review. No abstract available.
Cited by
- H2 inhalation therapy in patients with moderate COVID-19 (H2COVID): a prospective ascending-dose phase I clinical trial.
Salomez-Ihl C, Giai J, Barbado M, Paris A, Touati S, Alcaraz JP, Tanguy S, Leroy C, Lehmann A, Degano B, Gavard M, Bedouch P, Pavese P, Moreau-Gaudry A, Roustit M, Boucher F, Cinquin P, Brion JP. Salomez-Ihl C, et al. Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0057324. doi: 10.1128/aac.00573-24. Epub 2024 Jul 17. Antimicrob Agents Chemother. 2024. PMID: 39016593 Free PMC article. Clinical Trial. - Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice.
Guo Y, Qin J, Sun R, Hao P, Jiang Z, Wang Y, Gao Z, Zhang H, Xie K, Zhang W. Guo Y, et al. Biol Res. 2024 Jun 24;57(1):43. doi: 10.1186/s40659-024-00515-z. Biol Res. 2024. PMID: 38915069 Free PMC article. - Health Benefits of Electrolyzed Hydrogen Water: Antioxidant and Anti-Inflammatory Effects in Living Organisms.
Hu D, Kabayama S, Watanabe Y, Cui Y. Hu D, et al. Antioxidants (Basel). 2024 Mar 2;13(3):313. doi: 10.3390/antiox13030313. Antioxidants (Basel). 2024. PMID: 38539846 Free PMC article. Review. - Molecular Hydrogen Therapy-A Review on Clinical Studies and Outcomes.
Johnsen HM, Hiorth M, Klaveness J. Johnsen HM, et al. Molecules. 2023 Nov 26;28(23):7785. doi: 10.3390/molecules28237785. Molecules. 2023. PMID: 38067515 Free PMC article. Review. - Novel Role of Molecular Hydrogen: The End of Ophthalmic Diseases?
Li SY, Xue RY, Wu H, Pu N, Wei D, Zhao N, Song ZM, Tao Y. Li SY, et al. Pharmaceuticals (Basel). 2023 Nov 7;16(11):1567. doi: 10.3390/ph16111567. Pharmaceuticals (Basel). 2023. PMID: 38004433 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources